Prereceptor regulation of glucocorticoid action by 11β‐hydroxysteroid dehydrogenase: a novel determinant of cell proliferation
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Isozymes of 11β‐hydroxysteroid dehydrogenase (11β‐HSD) act at a prereceptor level to regulate the tissue‐specific availability of active glu‐cocorticoids. To examine the effect of this on cell proliferation and differentiation, we have developed transfectant variants of a rat osteosarcoma cell line that express cDNA for 11β‐HSD1 (ROS 17/2.8β1) or 11β‐HSD2 (ROS 17/2.8β2). ROS 17/2.8β1 showed net conversion of cortisone to cortisol whereas ROS 17/2.8β2 showed only inactivation of cortisol to cortisone. There was no significant difference in glucocorticoid receptor (GR) expression between the different clones. However, in proliferation and differentiation studies, ROS 17/2.8β2 cells were completely resistant to cortisol. In contrast, ROS 17/2.8β1 were sensitive to both cortisone and cortisol. Expression of 11β‐HSD1 de‐creased cell proliferation whereas 11β‐HSD2 increased proliferation. These responses appear to be due to metabolism of endogenous serum glucocorticoids; proliferation of ROS 17/2.8β1 decreased further with exogenous cortisone or cortisol whereas ROS 17/2.8β2 were resistant to both compounds. The pro‐prolifera‐tive effects of 11β‐HSD2 were abrogated by 18β‐glycyrrhetinic acid, an 11β‐HSD inhibitor, and in cells transfected with cDNA encoding inactive 11β‐HSD 2. Data indicate that differential regulation of 11β‐HSD1 and 2 (rather than GR expression) is a key determinant of cell proliferation. Dysregulated expression of 11β‐HSD2 may be a novel feature of tumorigenesis.—Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., Hewison, M. Prereceptor regulation of glucocorticoid action by 11β‐hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J. 16, 36–44 (2002)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805 · cited 4×
“Oxidative (dehydrogenase) 11-HSD activity was determined using unlabeled cortisol and corticosterone (10 ‐1000 nM for both) and tracer amounts (1 nM) of [1,2,6,7]-3H-cortisol or [1,2, 6 ,7]-3Hcorticosterone (specific activity for both: 70 ‐100 Ci/mmol; DuPont, Boston, MA) for 5 h. Steroids were extracted from”
MethodInfluentialTannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Li, K. X. Z., Obeyesekere, V. R., Krozowski, Z. S., & Ferrari, P. (1997) · Endocrinology · doi:10.1210/endo.138.7.5232 · Cited by 44
Cited by
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“inhibit cellular proliferation by inducing cell cycle arrest at the G1 phase (187, 188), and the prereceptor modulation of cortisol metabolism has a dramatic effect upon cell proliferation rate (189).”
Self-citation11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
Self-citationBone loss in inflammatory disorders
Hardy, R., & Cooper, M. S. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0568 · Cited by 365
Self-citationSchmidt, S., Rainer, J., Ploner, C., Presul, E., Riml, S., & Kofler, R. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401456 · Cited by 360
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Self-citationCooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Self-citationLi, C. Y., Stevens, K. R., Schwartz, R. E., Alejandro, B. S., Huang, J. H., & Bhatia, S. N. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0667 · Cited by 132
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
11β-Hydroxysteroid dehydrogenase: unexpected connections
Walker, E. A., & Stewart, P. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00134-6 · Cited by 72
Self-citationHwang, J.-Y., Lee, S. H., Kim, G. S., Koh, J.-M., Go, M. J., Kim, Y.-J., Kim, H.-C., Kim, T.-H., Hong, J. M., Park, E. K., et al. (2009) · Bone · doi:10.1016/j.bone.2009.07.080 · Cited by 55
“This enzyme, HSD11B1, is expressed in human osteoblasts in vivo [11], and both attenuates proliferation and induces differentiation of osteoblasts in vitro [12].”
BackgroundCooper, M. S., Syddall, H. E., Fall, C. H. D., Wood, P. J., Stewart, P. M., Cooper, C., & Dennison, E. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02281.x · Cited by 48
Raza, K., Hardy, R., & Cooper, M. S. (2010) · Rheumatology · doi:10.1093/rheumatology/keq212 · Cited by 31
Self-citation
Metadata
- Authors
- Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., & Hewison, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 16
- Issue
- 1
- Pages
- 36-44
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1987840607
- Cited by
- 88
- References
- 3
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.